159 related articles for article (PubMed ID: 38151580)
21. Noninvasive quantification of target availability during therapy using paired-agent fluorescence tomography.
Meng B; Folaron MR; Strawbridge RR; Sadeghipour N; Samkoe KS; Tichauer K; Davis SC
Theranostics; 2020; 10(24):11230-11243. PubMed ID: 33042280
[TBL] [Abstract][Full Text] [Related]
22. Cy5.5-labeled Affibody molecule for near-infrared fluorescent optical imaging of epidermal growth factor receptor positive tumors.
Miao Z; Ren G; Liu H; Jiang L; Cheng Z
J Biomed Opt; 2010; 15(3):036007. PubMed ID: 20615009
[TBL] [Abstract][Full Text] [Related]
23. Optimizing Glioma Detection Using an EGFR-Targeted Fluorescent Affibody.
Ribeiro de Souza AL; Marra K; Gunn J; Samkoe KS; Hull S; Paulsen KD; Pogue BW
Photochem Photobiol; 2018 Nov; 94(6):1167-1171. PubMed ID: 30129069
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of anlotinib, a multikinase angiogenesis inhibitor, in combination with epirubicin in preclinical models of soft tissue sarcoma.
Wang ZM; Zhang SL; Yang H; Zhuang RY; Guo X; Tong HX; Zhang Y; Lu WQ; Zhou YH
Cancer Med; 2020 May; 9(10):3344-3352. PubMed ID: 32181596
[TBL] [Abstract][Full Text] [Related]
25. Near infrared imaging of epidermal growth factor receptor positive xenografts in mice with domain I/II specific antibody fragments.
Bernhard W; El-Sayed A; Barreto K; Gonzalez C; Fonge H; Geyer CR
Theranostics; 2019; 9(4):974-985. PubMed ID: 30867810
[TBL] [Abstract][Full Text] [Related]
26. Human Epidermal Growth Factor Receptor 2-Targeting [
Alhuseinalkhudhur A; Lindman H; Liss P; Sundin T; Frejd FY; Hartman J; Iyer V; Feldwisch J; Lubberink M; Rönnlund C; Tolmachev V; Velikyan I; Sörensen J
J Nucl Med; 2023 Sep; 64(9):1364-1370. PubMed ID: 37442602
[TBL] [Abstract][Full Text] [Related]
27. MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Payne HL; Hoopes PJ; Paulsen KD; Pogue BW
Acad Radiol; 2010 Mar; 17(3):271-6. PubMed ID: 20152724
[TBL] [Abstract][Full Text] [Related]
28. Fluorescence molecular optomic signatures improve identification of tumors in head and neck specimens.
Chen Y; Streeter SS; Hunt B; Sardar HS; Gunn JR; Tafe LJ; Paydarfar JA; Pogue BW; Paulsen KD; Samkoe KS
Front Med Technol; 2023; 5():1009638. PubMed ID: 36875185
[TBL] [Abstract][Full Text] [Related]
29. Simultaneous
Elliott JT; Marra K; Evans LT; Davis SC; Samkoe KS; Feldwisch J; Paulsen KD; Roberts DW; Pogue BW
Clin Cancer Res; 2017 May; 23(9):2203-2212. PubMed ID: 27799250
[No Abstract] [Full Text] [Related]
30. Epidermal growth factor receptor-targeted molecular imaging of colorectal tumors: Detection and treatment evaluation of tumors in animal models.
Miyamoto Y; Muguruma N; Fujimoto S; Okada Y; Kida Y; Nakamura F; Tanaka K; Nakagawa T; Kitamura S; Okamoto K; Miyamoto H; Sato Y; Takayama T
Cancer Sci; 2019 Jun; 110(6):1921-1930. PubMed ID: 30973663
[TBL] [Abstract][Full Text] [Related]
31. Paired-agent imaging for detection of head and neck cancers.
Samkoe KS; Park Y; Marra K; Chen EY; Tichauer KM
Proc SPIE Int Soc Opt Eng; 2019 Feb; 10853():. PubMed ID: 31686720
[TBL] [Abstract][Full Text] [Related]
32. Fluorescent affibody peptide penetration in glioma margin is superior to full antibody.
Sexton K; Tichauer K; Samkoe KS; Gunn J; Hoopes PJ; Pogue BW
PLoS One; 2013; 8(4):e60390. PubMed ID: 23593208
[TBL] [Abstract][Full Text] [Related]
33. In-vivo imaging of oral squamous cell carcinoma by EGFR monoclonal antibody conjugated near-infrared quantum dots in mice.
Yang K; Zhang FJ; Tang H; Zhao C; Cao YA; Lv XQ; Chen D; Li YD
Int J Nanomedicine; 2011; 6():1739-45. PubMed ID: 21980236
[TBL] [Abstract][Full Text] [Related]
34. In vivo molecular imaging of colorectal cancer with confocal endomicroscopy by targeting epidermal growth factor receptor.
Goetz M; Ziebart A; Foersch S; Vieth M; Waldner MJ; Delaney P; Galle PR; Neurath MF; Kiesslich R
Gastroenterology; 2010 Feb; 138(2):435-46. PubMed ID: 19852961
[TBL] [Abstract][Full Text] [Related]
35. Use of fluorescent labeled anti-epidermal growth factor receptor antibody to image head and neck squamous cell carcinoma xenografts.
Rosenthal EL; Kulbersh BD; King T; Chaudhuri TR; Zinn KR
Mol Cancer Ther; 2007 Apr; 6(4):1230-8. PubMed ID: 17431103
[TBL] [Abstract][Full Text] [Related]
36. The role of neoadjuvant radiochemotherapy in the management of localized high-grade soft tissue sarcoma.
Kobus M; Roohani S; Ehret F; Flörcken A; Striefler JK; Brandes F; Märdian S; Rau D; Wittenberg S; Öllinger R; Kaul D
Radiat Oncol; 2022 Aug; 17(1):139. PubMed ID: 35941656
[TBL] [Abstract][Full Text] [Related]
37. Affibody-Based PET Imaging to Guide EGFR-Targeted Cancer Therapy in Head and Neck Squamous Cell Cancer Models.
Burley TA; Da Pieve C; Martins CD; Ciobota DM; Allott L; Oyen WJG; Harrington KJ; Smith G; Kramer-Marek G
J Nucl Med; 2019 Mar; 60(3):353-361. PubMed ID: 30213849
[TBL] [Abstract][Full Text] [Related]
38. Pediatric Soft Tissue Tumors With BCOR ITD Express EGFR but Not OLIG2.
Salgado CM; Zin A; Garrido M; Kletskaya I; DeVito R; Reyes-Múgica M; Bisogno G; Donofrio V; Alaggio R
Pediatr Dev Pathol; 2020; 23(6):424-430. PubMed ID: 32790583
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
